Literature DB >> 3013350

Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breast.

T Ito, S Saga, S Nagayoshi, M Imai, A Aoyama, T Yokoi, M Hoshino.   

Abstract

A class distribution of plasma cells associated with the stroma in twenty-eight cases of medullary carcinoma of the breast was investigated by an unlabeled immunoperoxidase method. The stroma of the medullary carcinomas tested was found to contain predominantly IgG plasma cells except in two cases. Stroma of the other types of breast carcinoma, including ten cases of papillo-tubular carcinoma, five cases of scirrhous carcinoma, and six cases of medullary tubular carcinoma, contained predominantly IgG plasma cells, although few plasma cells were associated with carcinoma tissues in the latter group. Plasma cells associated with control specimens, including normal breast, fibroadenoma, cystic disease, and intraductal papilloma, were found to be predominantly of IgA type. Few carcinomatous epithelial cells contained secretory components in the cytoplasm, while a number of cells positive for secretory components were observed in acinar and ductular epithelia of normal breast tissues and in benign proliferative lesions of the breast. It is suggested that the lymphoid cells infiltrating the stroma of medullary carcinoma represent a sign of host immune response against the carcinoma cells which is related to the well-known favorable prognosis associated with this tumor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013350     DOI: 10.1007/bf01806794

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  17 in total

1.  A COMPARISON OF SURVIVAL RATES BETWEEN AMERICAN AND JAPANESE PATIENTS WITH BREAST CANCER.

Authors:  E L WYNDER; T KAJITANI; J KUNO; J C LUCAS; A DEPALO; J FARROW
Journal:  Surg Gynecol Obstet       Date:  1963-08

2.  Histologic differences in breast carcinoma of Japanese and American women.

Authors:  A B Chabon; S Takeuchi; S C Sommers
Journal:  Cancer       Date:  1974-06       Impact factor: 6.860

3.  Some international differences in histology and survival in breast cancer.

Authors:  A S Morrison; M M Black; C R Lowe; B MacMahon; S Yuasa
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

4.  Sinus histiocytosis in British and Japanese patients with breast cancer.

Authors:  G H Friedell; E A Soto; S Kumaoka; O Abe; J L Hayward; R D Bulbrook
Journal:  Lancet       Date:  1974-11-23       Impact factor: 79.321

5.  Medullary carcinoma of breast: an immunohistochemical study of its lymphoid stroma.

Authors:  S M Hsu; L Raine; R N Nayak
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

Review 6.  Cellular aspects of immunoglobulin A.

Authors:  M E Lamm
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

7.  The immunohistochemical reactivity of a human monoclonal antibody with tissue sections of human mammary tumors.

Authors:  Y A Teramoto; R Meriani; D Wunderlich; J Schlom
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

8.  Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera.

Authors:  I Shimokawara; M Imamura; N Yamanaka; Y Ishii; K Kikuchi
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

9.  Plasma IgA, IgG and IgM and their relationship to breast cancer in British, Japanese and Hawaiian-Japanese women.

Authors:  D Y Wang; P R Goodwin; R D Bulbrook; J L Hayward; O Abe; J Utsunomiya; S Kumaoka; F C Greenwood; G Glober; G Stemmerman
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

10.  Immunoglobulin localization in benign and malignant lesions of the human mammary gland.

Authors:  K S McCarty; J W Grant; N Georgiade; W Wilkinson; R Graham; B J Ferguson; D Deubner; K S McCarty; H F Seigler
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

View more
  6 in total

1.  For breast cancer prognosis, immunoglobulin kappa chain surfaces to the top.

Authors:  Theresa L Whiteside; Soldano Ferrone
Journal:  Clin Cancer Res       Date:  2012-03-22       Impact factor: 12.531

2.  Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.

Authors:  Peter Simsa; Jean-Luc Teillaud; David I Stott; József Tóth; Beatrix Kotlan
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

Review 3.  B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.

Authors:  Wolf H Fridman; Maxime Meylan; Florent Petitprez; Cheng-Ming Sun; Antoine Italiano; Catherine Sautès-Fridman
Journal:  Nat Rev Clin Oncol       Date:  2022-04-01       Impact factor: 65.011

4.  Immune aspects of the breast tumor microenvironment.

Authors:  Akhil Chawla; Gheath Alatrash; Yun Wu; Elizabeth A Mittendorf
Journal:  Breast Cancer Manag       Date:  2013-05-01

Review 5.  Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers.

Authors:  Yasmine Lounici; Olivia Le Saux; Gabriel Chemin; Pauline Wajda; Sarah Barrin; Justine Berthet; Christophe Caux; Bertrand Dubois
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

6.  High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer.

Authors:  Joe Yeong; Jeffrey Chun Tatt Lim; Bernett Lee; Huihua Li; Noel Chia; Clara Chong Hui Ong; Weng Kit Lye; Thomas Choudary Putti; Rebecca Dent; Elaine Lim; Aye Aye Thike; Puay Hoon Tan; Jabed Iqbal
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.